Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1622 1627
This examiner grants 40% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17854066 | PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS | Final Rejection | Sun Pharmaceutical Industries, Inc. |
| 19094303 | METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER | Non-Final OA | Xenon Pharmaceuticals Inc. |
| 18679045 | METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER | Non-Final OA | Xenon Pharmaceuticals Inc. |
| 18648049 | METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER | Non-Final OA | Xenon Pharmaceuticals Inc. |
| 17534888 | SHIKIMATE ANALOGUES AND METHODS OF USE | Final Rejection | The Board of Regents of the University of Oklahoma |
| 17622395 | EXTERNAL PREPARATION FOR SKIN | Final Rejection | KAO CORPORATION |
| 16446718 | Process For Formation of Emulsion Containing Liquid Crystal Structure | Non-Final OA | Kenvue Brands LLC |
| 17925775 | Methods and Compositions for Treating Pain While Minimizing the Risk of Opioid Addiction | Non-Final OA | The United States Government as Represented by the Department of Veterans Affairs |
| 18598526 | PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB FOR ORAL ADMINISTRATION | Non-Final OA | HIKMA PHARMACEUTICALS USA INC. |
| 17443766 | STABLE AQUEOUS INJECTABLE SOLUTION OF EPINEPHRINE | Final Rejection | Sun Pharmaceutical Industries Limited |
| 18422543 | PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN | Non-Final OA | REBEL MEDICINE INC |
| 18345760 | Method and Formulation for Improving Roflumilast Skin Penetration Lag Time | Non-Final OA | ARCUTIS Biotherapeutics, Inc. |
| 18044358 | DERMAL COMPOSITIONS REPLICATING THE VERNIX CASEOSA | Non-Final OA | APR Applied Pharma Research SA |
| 18001313 | BIOAVAILABLE SUGAR-BASED DICLOFENAC FORMULATIONS | Non-Final OA | APR Applied Pharma Research SA |
| 17924859 | COMPOSITIONS FOR DELIVERY OF BIOACTIVE AGENTS INTO HAIR FOLLICLES | Non-Final OA | FOLLICLE PHARMA LTD |
| 17981038 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | Non-Final OA | Berg LLC |
| 17784243 | LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINE | Final Rejection | Adamed Pharma S.A. |
| 17811347 | TREATMENT OF HAND ECZEMA | Final Rejection | LEO Pharma A/S |
| 17621614 | COMPOSITION COMPRISING POLAR LIPIDS AND METHOD OF MAKING SAME | Final Rejection | ALGANNOVATION LTD |
| 15931944 | ADMINISTRATION OF DEUTERATED CFTR POTENTIATORS | Non-Final OA | Vertex Pharmaceuticals (Europe) Limited |
| 16347587 | Therapeutic Cannabinoid Formulations and Methods for Their Use | Non-Final OA | Avidas Pharmaceuticals LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy